Sasanlimab
pfizer
['pfizer']
in , see updated results of a phase 1 dose expansion study evaluating the safety and efficacy of an anti-pd-1 mab in patients with locally advanced or metastatic non-small cell #lungcancer and #urothelialcarcinoma 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/0NA3Dn8crN